patents.google.com

NL7900766A - METHOD FOR PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS. - Google Patents

  • ️Wed Aug 08 1979

NL7900766A - METHOD FOR PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS. - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS.

Info

Publication number
NL7900766A
NL7900766A NL7900766A NL7900766A NL7900766A NL 7900766 A NL7900766 A NL 7900766A NL 7900766 A NL7900766 A NL 7900766A NL 7900766 A NL7900766 A NL 7900766A NL 7900766 A NL7900766 A NL 7900766A Authority
NL
Netherlands
Prior art keywords
prevention
treatment
rheumatoid arthritis
rheumatoid
arthritis
Prior art date
1978-02-06
Application number
NL7900766A
Other languages
Dutch (nl)
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1978-02-06
Filing date
1979-01-31
Publication date
1979-08-08
1979-01-31 Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
1979-08-08 Publication of NL7900766A publication Critical patent/NL7900766A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0266Klebsiella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0283Shigella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL7900766A 1978-02-06 1979-01-31 METHOD FOR PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS. NL7900766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87514078A 1978-02-06 1978-02-06

Publications (1)

Publication Number Publication Date
NL7900766A true NL7900766A (en) 1979-08-08

Family

ID=25365266

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7900766A NL7900766A (en) 1978-02-06 1979-01-31 METHOD FOR PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS.

Country Status (10)

Country Link
JP (1) JPS54113425A (en)
CH (1) CH651210A5 (en)
DE (1) DE2904044C2 (en)
DK (1) DK158138C (en)
FR (1) FR2416015A1 (en)
GB (1) GB2013691B (en)
HK (1) HK30283A (en)
IT (1) IT1116524B (en)
NL (1) NL7900766A (en)
SE (1) SE448344B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
ATE14269T1 (en) * 1981-02-26 1985-08-15 Unilever Nv METHOD AND DEVICE FOR RECOVERING IMMUNOGLOBULINES.
EP0064103B1 (en) * 1981-04-28 1985-11-06 The Stolle Research And Development Corporation Method of obtaining an anti-inflammatory bovine milk
JP2561234B2 (en) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション Anti-inflammatory agent
JPS58154513A (en) * 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho Preventive and remedying drug
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
DE3378890D1 (en) * 1983-06-07 1989-02-16 Stolle Res & Dev Deodorant containing bacterial antibodies
JPS6112629A (en) * 1984-06-28 1986-01-21 Lion Corp Composition for oral cavity application
ATE87215T1 (en) * 1987-07-21 1993-04-15 Stolle Res & Dev METHOD OF OBTAINING IMMUNO-REGULATORY FACTORS USING MAMMALIAN IMMUNIZATION.
JP2664906B2 (en) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション Improved mammalian immunization
WO2000062806A1 (en) * 1999-04-19 2000-10-26 Richard Weisbart Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
CA2423805A1 (en) * 2000-09-28 2002-04-04 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g
CA2437095A1 (en) * 2001-01-30 2002-10-10 The Lauridsen Group, Incorporated Methods and compositions for modulating the immune system of animals
EP1357942A2 (en) * 2001-01-30 2003-11-05 The Lauridsen Group Incorporated Methods and compositions for treatment of immune dysfunction disorders
JP4960632B2 (en) * 2006-01-10 2012-06-27 学校法人北里研究所 Composition for treating and preventing herpes simplex virus infection comprising immune milk composition as active ingredient
JP5361132B2 (en) * 2006-03-10 2013-12-04 国立大学法人信州大学 An oral immunomodulator containing immunoglobulin G, a method for producing the same, and a food or drink comprising the oral immunomodulator
JP2008179572A (en) * 2007-01-25 2008-08-07 Shinshu Univ Immunoglobulin Fc fragment receptor protein and / or immunoglobulin Fc fragment receptor-like protein production inhibitor and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH488013A (en) * 1965-10-24 1970-03-31 Immune Milk Company Of America Process for the production of antitoxins
DE1617769A1 (en) * 1967-06-10 1971-04-01 Rehm Eberhard Process for the production of milk containing specific antibodies and preparations made therefrom
JPS5136326A (en) * 1974-09-24 1976-03-27 Komatsu Seiren Co SEIKEIGORU FUBOORU
JPS5837285B2 (en) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ It is very difficult to understand the situation.
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
JPS5381613A (en) * 1976-12-28 1978-07-19 Green Cross Corp:The Remedies for enteral infection diseases
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin

Also Published As

Publication number Publication date
CH651210A5 (en) 1985-09-13
IT1116524B (en) 1986-02-10
FR2416015A1 (en) 1979-08-31
DK158138B (en) 1990-04-02
SE7900798L (en) 1979-08-07
FR2416015B1 (en) 1983-06-17
DK158138C (en) 1990-08-27
HK30283A (en) 1983-09-02
JPH0160455B2 (en) 1989-12-22
GB2013691A (en) 1979-08-15
GB2013691B (en) 1982-08-18
DE2904044A1 (en) 1979-08-30
DK49479A (en) 1979-08-07
JPS54113425A (en) 1979-09-05
IT7947888A0 (en) 1979-02-05
DE2904044C2 (en) 1986-02-06
SE448344B (en) 1987-02-16

Similar Documents

Publication Publication Date Title
NL7903039A (en) 1979-10-22 METHOD AND EQUIPMENT FOR THE TREATMENT AND PROCESSING OF METAL SNAIL.
NL7904607A (en) 1979-12-28 METHOD OF TREATING WATER.
NL7900872A (en) 1979-08-07 METHOD OF TREATING HYPERLIPOPROTEINEMIA AND HYPERLIPIDEMIA.
NL7900748A (en) 1979-08-01 METHOD AND DEVICE FOR COMPENSATION OF SCANNING DEVICES.
NL7710901A (en) 1979-04-09 PROCESS FOR THE SIMULTANEOUS PROCESSING OF USED METAL AND / OR METAL WASTE FROM HALOGENATED HYDROCARBONS.
NL7805527A (en) 1978-11-27 METHOD OF TREATING WHEY.
NL7900766A (en) 1979-08-08 METHOD FOR PREVENTION AND TREATMENT OF RHEUMATOID ARTHRITIS.
NL7611122A (en) 1977-05-03 METHOD AND EQUIPMENT FOR THE PREPARATION AND INCINERATION OF WASTE.
NL7606685A (en) 1977-01-18 METHOD OF TREATING WASTE.
NL7700538A (en) 1977-07-26 METHOD AND EQUIPMENT FOR TREATING POWDER OR GRANULAR SUBSTANCES.
NL7902496A (en) 1979-10-02 METHOD FOR SELECTIVE DESULFURIZATION OF CRACKED NAFTA.
NL191088C (en) 1995-01-16 Method of forming and treating steel bar.
NL7904393A (en) 1979-12-07 METHOD FOR TREATING SURFACES.
NL7812251A (en) 1979-10-23 METHOD OF TREATING LIQUID WHEY.
NL190707B (en) 1994-02-01 METHOD AND APPARATUS FOR GASIFICATION OF COAL
NL7707061A (en) 1978-05-24 METHOD AND ESTABLISHMENT FOR THE TREATMENT OF METAL CONTAINING WASTE WATER.
NL7900583A (en) 1979-07-30 METHOD OF TREATING WASTE.
NL7810825A (en) 1979-05-02 METHOD AND SYSTEM FOR PROCESSING ARAB FARSITALS.
NL7812294A (en) 1979-09-17 METHOD AND EQUIPMENT FOR THE MANUFACTURE OF BAGS.
NL7812164A (en) 1979-06-29 METHOD FOR TREATING HYPERTENSION AND RELATED MEDICINES
NL7806660A (en) 1979-02-12 METHOD AND EQUIPMENT FOR THE TREATMENT OF WASTE WATER.
NL7701902A (en) 1977-09-05 METHOD AND DEVICE FOR TREATING THE INSIDE OF PIPES AND PIPES.
NL7713636A (en) 1978-06-15 METHOD AND EQUIPMENT FOR THE PURIFICATION OF WASTE WATER.
NL7902211A (en) 1979-09-25 METHOD OF HANDLING POLYMER MUCH.
NL190484C (en) 1994-03-16 Apparatus and method for the chemical treatment of sludge.

Legal Events

Date Code Title Description
1979-12-27 BA A request for search or an international-type search has been filed
1980-09-25 BB A search report has been drawn up
1985-01-01 A85 Still pending on 85-01-01
1986-03-03 BC A request for examination has been filed
1999-10-01 BV The patent application has lapsed